In the fast-paced world of smartphones, a fierce rivalry has shaped the industry for over a decade. On one side, Apple, the epitome of…
Q&A with AzarGen Biotechnologies on $3.1m funding round
Starting 2016 with a bang, VC4Africa-listed venture AzarGen Biotechnologies closes US$3.1-million in Series B funding. VC4A had a chance to speak with Dr. Mauritz…